MODD Modular Medical Inc
249
$1.72
$0.03
(1.77%)
| Watchers | 249 |
| 52-Wk Low | $0.84 |
| 52-Wk High | $2.22 |
| Market Cap | $52.37M |
| Volume | 62,247.00 |
| 52-Wk High | $2.22 |
| 52-Wk Low | $0.84 |
Modular Medical appoints Steve Gemmell as VP, engineeringThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ('Modular Medical' or the 'Company'), a development-stage, insulin delivery technology company seeking to launch the...
Benchmark reissued their speculative buy rating on shares of Modular Medical (NASDAQ:MODD Free Report) in a research note released on Thursday, Benzinga reports. Benchmark currently has a...
Modular Medical (NASDAQ:MODD Get Free Report)s stock had its speculative buy rating reiterated by research analysts at Benchmark in a research report issued to clients...
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin...
SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ('Modular Medical' or the 'Company'), a development stage insulin delivery technology company seeking to launch...
Modular Medical drops 7%, prices $10M share offering...
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ('Modular Medical' or the 'Company'), a development stage insulin delivery technology company seeking to launch...
Modular Medical announces proposed underwritten public offering...
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ('Modular Medical'), a development stage insulin delivery technology company seeking to launch the next generation...